Coronary artery ectasia: a ten-year experience in a tertiary hospital in Singapore

C S P Lam1, K T Ho

  • 1Cardiac Department, The Heart Institute, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074.

Insights

The incidence of coronary artery ectasia (CAE) in Singapore is 1.2%, primarily affecting males in their fifth decade. Most patients had co-existing obstructive coronary artery disease, with the right coronary artery most frequently involved.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Coronary artery ectasia (CAE) is a rare angiographic finding characterized by abnormal coronary dilatation.
  • The incidence of CAE has not been previously described in Singapore.

Purpose of the Study:

  • To determine the incidence of CAE at a Singaporean teaching hospital.
  • To characterize the patient demographics and angiographic features of CAE.

Main Methods:

  • Retrospective review of coronary angiography records from 1992-2001.
  • Identification of CAE cases through a hospital computer database search.

Main Results:

  • An incidence of 1.2% for CAE was observed in 104 out of 8641 patients.
  • The majority of affected patients were male (74%), with a median age of 54, and common comorbidities included hypertension (58%) and dyslipidemia (63%).
  • The right coronary artery (RCA) was most commonly affected (65%), with 82% of cases showing co-existent obstructive coronary artery disease.

Conclusions:

  • The incidence of coronary artery ectasia in this Singaporean cohort is 1.2%.
  • CAE predominantly affects middle-aged males and is frequently associated with obstructive coronary artery disease.
  • The right coronary artery is the most commonly involved vessel, often presenting as single-vessel ectasia.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...